Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,248) Arrow Down
Filter Results: (1,248) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)

Show Results For

  • All HBS Web  (1,248)
    • People  (5)
    • News  (172)
    • Research  (929)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (759)
← Page 27 of 1,248 Results →

    Joey Ryu

    Joey (Won Jung) Ryu is a doctoral student in the Strategy unit at Harvard Business School. Her primary interests are strategic management, economics of innovation and entrepreneurship. Prior to joining HBS, Joey received her master's degree from Cornell University... View Details
    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • 01 Feb 2022
    • Book

    Innovation Isn’t Just for Startups: How Big Companies Can Succeed

    traditional core. She hired computational chemists, genetic scientists, and pharmaceutical business experts. They dressed and spoke differently from the famously staid IBM executive. The best Corporate Explorers not only disrupt the... View Details
    Keywords: by Lane Lambert
    • 31 Oct 2023
    • News

    Securing a Resilient Future for Senegal

    Special Drawing Rights (international reserve assets that supplement a country’s official reserves); and negotiating agreements to fund some of flagship projects laid out in the 2019–2023 Priority Action Plan, a development model that supports growth through economic... View Details
    • 19 Apr 2004
    • Research & Ideas

    Birth of the American Salesman

    This figure includes all types of sellers, from pharmaceutical sales workers to counterpersons at department stores; it is up from about 5 percent in 1920 and 7 percent in 1960. Of the 16 million people working in sales in 2000, about 10... View Details
    Keywords: by Laura Linard
    • December 2019
    • Case

    The Business of Pain: Johnson & Johnson and the Promise of Opioids

    By: Erik Snowberg, Trevor Fetter and Amy W. Schulman
    This case is designed to provide an engrossing overview of stakeholder capitalism through a vigorous discussion of the conflicts that can arise when trying to serve multiple stakeholders. In 2007, Johnson & Johnson’s (J&J) subsidiary Janssen has to decide whether or... View Details
    Keywords: Opioids; Addiction; Stakeholder Capitalism; Business and Stakeholder Relations; Product Launch; Decision Making; Ethics; Social Issues; Pharmaceutical Industry
    Citation
    Educators
    Purchase
    Related
    Snowberg, Erik, Trevor Fetter, and Amy W. Schulman. "The Business of Pain: Johnson & Johnson and the Promise of Opioids." Harvard Business School Case 720-420, December 2019.
    • Web

    For Recruiters - Health Care

    systems, e-health firms, pharmaceutical companies, medical device manufacturers, and biotechnology companies. Hire a Summer Intern Summer internships are valuable for both employers and students as a “test run.” Employers benefit most... View Details

      John T. Gourville

      John Gourville is the Albert J. Weatherhead, Jr. Professor of Business Administration at the Harvard Business School.  He joined the HBS Marketing Unit in 1995 after receiving his Ph.D. at the University of Chicago in marketing and behavioral research.  His most... View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • 15 Nov 2018
      • Book

      Can the Global Food Industry Overcome Public Distrust?

      JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
      Keywords: by Sean Silverthorne; Agriculture & Agribusiness
      • March 2023 (Revised March 2023)
      • Case

      Roche: Innovation and Access to Healthcare

      By: George Serafeim, Susanna Gallani and Benjamin Maletta
      In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details
      Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
      Citation
      Educators
      Purchase
      Related
      Serafeim, George, Susanna Gallani, and Benjamin Maletta. "Roche: Innovation and Access to Healthcare." Harvard Business School Case 123-075, March 2023. (Revised March 2023.)
      • Web

      Recruiting Partners - Health Care

      Pharmaceuticals Alpha Edison AMAG Pharmaceuticals Amarin Corporation American Tinnitus Association American Well AmerisourceBergen Amgen, Inc. Amicoat AS Amicus Therapeutics Amnisure International LLC... View Details

        Elon Kohlberg

        Elon Kohlberg is the Royal Little Professor of Business Administration at the Harvard Business School. His research is mainly in Game Theory, in particular the study of non-cooperative equilibrium.

        Professor Kohlberg has taught many courses in the MBA,... View Details

        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
        • 01 Dec 2019
        • News

        Remix

        exercise of getting the mix just right “had almost a pharmaceutical effect on me,” she says. Hip-hop, though, hit a nerve. “I liked the nerdy braininess of digging into the lyrics and wordplay, but it also mashed up the soundtrack of my... View Details
        Keywords: Jen McFarland Flint; photographed by Chris Sorensen; #MeToo; DefJam; Arts, Entertainment
        • 10 Apr 2014
        • Research & Ideas

        John Kotter’s Plan to Accelerate Your Business

        other more rational. In a typical organization—from the federal government to a pharmaceutical giant—a hierarchical operational structure meets daily demands through clear reporting relationships and responsibilities, Kotter writes. This... View Details
        Keywords: by Kim Girard
        • September 2010 (Revised July 2013)
        • Case

        Alnylam Pharmaceuticals: Building Value from the IP Estate

        By: Willy C. Shih and Sen Chai
        The learning objective of this case is to help students recognize the interplay between intellectual property (IP) rights and corporate strategy. We do this by examining what is a fairly atypical circumstance today in which a single firm is able to secure what it... View Details
        Keywords: Patents; Lawsuits and Litigation; Rights; Competitive Strategy; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; United States
        Citation
        Educators
        Purchase
        Related
        Shih, Willy C., and Sen Chai. "Alnylam Pharmaceuticals: Building Value from the IP Estate." Harvard Business School Case 611-009, September 2010. (Revised July 2013.)
        • February 2024
        • Case

        Compass Pathways: Pioneering Psychedelic Treatment

        By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu
        This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no... View Details
        Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Testing and Trials; Research and Development; Laws and Statutes; Pharmaceutical Industry; Europe; United States; United Kingdom
        Citation
        Educators
        Purchase
        Related
        Zuzul, Tiona, Kisha Lashley, and Gamze Yucaoglu. "Compass Pathways: Pioneering Psychedelic Treatment." Harvard Business School Case 724-412, February 2024.
        • February 2010 (Revised September 2011)
        • Case

        Roche's Acquisition of Genentech

        By: Carliss Y. Baldwin, Bo Becker and Vincent Marie Dessain
        Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, the pros and... View Details
        Keywords: Mergers and Acquisitions; Business Subsidiaries; Negotiation Offer; Organizational Culture; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
        Citation
        Educators
        Purchase
        Related
        Baldwin, Carliss Y., Bo Becker, and Vincent Marie Dessain. "Roche's Acquisition of Genentech." Harvard Business School Case 210-040, February 2010. (Revised September 2011.)
        • May 1998 (Revised May 1999)
        • Case

        Biopure Corp.

        By: John T. Gourville
        It is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood... View Details
        Keywords: Segmentation; Marketing Strategy; Engineering; Budgets and Budgeting; Sales; Transformation; Markets; Debates; Product Launch; Pharmaceutical Industry
        Citation
        Educators
        Purchase
        Related
        Gourville, John T. "Biopure Corp." Harvard Business School Case 598-150, May 1998. (Revised May 1999.)
        • October 2022
        • Case

        Cost Plus Drugs

        By: Alexander MacKay and James Barnett
        In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies.... View Details
        Keywords: Business Ventures; Decision Making; Entrepreneurship; Ethics; Health; Markets; Social Enterprise; Society; Strategy; Health Care and Treatment; Business Divisions; Factories, Labs, and Plants; Pharmaceutical Industry; Pharmaceutical Industry; United States; Texas
        Citation
        Educators
        Purchase
        Related
        MacKay, Alexander, and James Barnett. "Cost Plus Drugs." Harvard Business School Case 723-362, October 2022.
        • 01 Feb 1999
        • News

        Too Much of a Good Thing?

        years, sectors as diverse as automobiles, semiconductors, steel, textiles, consumer electronics, tires, and pharmaceuticals have been afflicted by overcapacity and some or all of its unpleasant side effects: loss of jobs, plant closings,... View Details
        Keywords: Garry Emmons
        • Web

        Strategy for Health Care Delivery - Institute For Strategy And Competitiveness

        Clinic) as part of their business model Senior executives from nonprofit organizations that deliver health care services Executives from health care insurance companies, government entities that pay for health care, or other payor organizations Leaders from View Details
        • ←
        • 27
        • 28
        • …
        • 62
        • 63
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.